GlaxoSmithKline Plc Consumer Products As Company Plans Spinoff

Tums antacid tablets, manufactured by GlaxoSmithkline Plc, arranged in Danbury, U.K., on Monday, June 28, 2021. The U.K. company will list the consumer unit, which makes products such as Sensodyne toothpaste and Nicorette gum, in mid-2022 on the London Stock Exchange. Photographer: Chris Ratcliffe/Bloomberg via Getty Images

GlaxoSmithKline Plc Consumer Products As Company Plans Spinoff
Tums antacid tablets, manufactured by GlaxoSmithkline Plc, arranged in Danbury, U.K., on Monday, June 28, 2021. The U.K. company will list the consumer unit, which makes products such as Sensodyne toothpaste and Nicorette gum, in mid-2022 on the London Stock Exchange. Photographer: Chris Ratcliffe/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesGlaxoSmithKline Plc Consumer Products As Company Plans Spinoff, News PhotoGlaxoSmithKline Plc Consumer Products As Company Plans Spinoff, News PhotoGlaxoSmithKline Plc Consumer Products As Company Plans Spinoff Get premium, high resolution news photos at Getty ImagesProduct #:1233713917
$499$175
Getty Images
In stock

DETAILS

Credit: Bloomberg / Contributor

Getty Images editorial coverage is captured by expert trusted visual journalists. Learn more about our editorial policies.

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Editorial #:
1233713917
Collection:
Bloomberg
Date created:
June 28, 2021
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
UK GSK
Max file size:
4000 x 2634 px (13.33 x 8.78 in) - 300 dpi - 2 MB